Recent research has found that fewer than 1 in 1,000 US adolescents receive gender-affirming medications, indicating that only a small percentage of transgender youth are accessing this essential medical care. Specifically, studies show that less than 0.1 percent of teenagers are prescribed puberty blockers or gender-affirming hormones. This highlights a significant gap in healthcare for transgender minors, with many being left without necessary treatments, as only a very small number of adolescents are benefiting from available gender-affirming care.